We predict that the availability of SACS mutation analysis as well as an increasing awareness of the characteristic ARSACS phenotype will lead to the diagnosis of many additional patients, possibly even at a younger age.
C1849140
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE